Related Experiment Video

Updated: Oct 2, 2025

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.2K

Banking on metabolomics for novel therapies in TNBC

Aurelien Tripp1, George Poulogiannis2

  • 1Signalling and Cancer Metabolism Team, Division of Cancer Biology, The Institute of Cancer Research, London, UK.

Cell Research
|March 1, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

684
Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

10.6K

Related Experiment Videos

Last Updated: Oct 2, 2025

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.2K
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

684
Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

10.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K

Articles linked to this work by shared authors, journal, and citation graph.

RNA terminal uridylyl transferases are druggable vulnerabilities in AML but are dispensable for normal hematopoiesis.

Science advances·2026

WNK1 signalling regulates amino acid transport and mTORC1 activity to sustain acute myeloid leukaemia growth.

Nature communications·2025

Harnessing the Power of Metabolomics for Precision Oncology: Current Advances and Future Directions.

Cells·2025

Visualizing Cancer Heterogeneity at the Molecular and Cellular Levels: Lessons from Rosetta.

Cancer discovery·2025

Testing of rapid evaporative mass spectrometry for histological tissue classification and molecular diagnostics in a multi-site study.

British journal of cancer·2024

A novel Nav1.5-dependent feedback mechanism driving glycolytic acidification in breast cancer metastasis.

Oncogene·2024

p-LoopF is associated with chromatin looping in large introns of Ginkgo biloba.

Cell research·2026

Cold exposure aggravates vein occlusion through non-shivering thermogenesis-induced thrombocytopoiesis.

Cell research·2026

Ferroptotic propagation: from single-cell execution to tissue-scale death programs.

Cell research·2026

TRIM37 interacts with TRIM28 to maintain primordial germ cell identity during migration.

Cell research·2026

A universal 6iL/E4 culture system for deriving and maintaining embryonic stem cells across mammalian species.

Cell research·2026

Genome-wide profiling of histone modifications and transcription factor binding at single-cell resolution by DeChIC-seq.

Cell research·2026

Investigating Mitochondrial Bioenergetics in Intact Heart and Brain Tissue Slices.

Current protocols·2026

Correction to "Detecting Bacteria in Their Mammalian Hosts Using Metabolism-Targeted [13C]CO2 Breath Testing".

ACS central science·2026

Metabolic dysfunction-associated steatotic liver disease as a systemic disorder: extrahepatic manifestations and the need for data-driven phenotyping.

Frontiers in endocrinology·2026

From obesity to healthy longevity: a consensus-based clinical framework for diagnosis, staging, and treatment.

Frontiers in aging·2026

A distinct serum metabolic profile characterizes osteosarcopenia: identifying potential metabolic biomarkers.

Frontiers in endocrinology·2026

Association of one-hour postload plasma glucose combined with metabolic dysfunction-associated steatotic liver disease and FIB-4 screening positivity with elevated LDL cholesterol and cerebrovascular stenosis.

Frontiers in endocrinology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us